[A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].


Journal

Arerugi = [Allergy]
ISSN: 0021-4884
Titre abrégé: Arerugi
Pays: Japan
ID NLM: 0241212

Informations de publication

Date de publication:
2023
Historique:
medline: 17 11 2023
pubmed: 16 11 2023
entrez: 15 11 2023
Statut: ppublish

Résumé

Little is known whether sublingual immunotherapy using Japanese cedar pollen extract (cedar SLIT) is effective for not only Japanese cedar pollinosis but also Japanese cypress pollinosis. We investigated the prevalence rate of Japanese cypress pollinosis, efficacy of cedar SLIT on cypress pollinosis and patients' wish to receive cypress SLIT. We investigated a multi-center (31 institutions), cross-sectional survey using a self-administrated questionnaire with four questions for patients received cedar SLIT aged from 5 to 69 years old. 2523 subjects were enrolled for analysis. 83.4% of them had pollinosis symptoms during cypress season before cedar SLIT. In such patients, 37.4% experienced lessened efficacy of cedar SLIT during cypress season. Both the prevalence of cypress pollinosis and the lessened efficacy of cedar SLIT on cypress pollinosis were significantly seen in western Japan as compared to eastern Japan. 76.1% of the subject having cypress pollinosis before SLIT wished to receive cypress SLIT if it is available. A lessened efficacy of cedar SLIT during cypress season was broadly seen in Japan, and further showed a regional difference. Together with the finding of high wish by patients, these results suggest a development of cypress SLIT is desirable.

Sections du résumé

BACKGROUND BACKGROUND
Little is known whether sublingual immunotherapy using Japanese cedar pollen extract (cedar SLIT) is effective for not only Japanese cedar pollinosis but also Japanese cypress pollinosis. We investigated the prevalence rate of Japanese cypress pollinosis, efficacy of cedar SLIT on cypress pollinosis and patients' wish to receive cypress SLIT.
METHODS METHODS
We investigated a multi-center (31 institutions), cross-sectional survey using a self-administrated questionnaire with four questions for patients received cedar SLIT aged from 5 to 69 years old.
RESULTS RESULTS
2523 subjects were enrolled for analysis. 83.4% of them had pollinosis symptoms during cypress season before cedar SLIT. In such patients, 37.4% experienced lessened efficacy of cedar SLIT during cypress season. Both the prevalence of cypress pollinosis and the lessened efficacy of cedar SLIT on cypress pollinosis were significantly seen in western Japan as compared to eastern Japan. 76.1% of the subject having cypress pollinosis before SLIT wished to receive cypress SLIT if it is available.
CONCLUSION CONCLUSIONS
A lessened efficacy of cedar SLIT during cypress season was broadly seen in Japan, and further showed a regional difference. Together with the finding of high wish by patients, these results suggest a development of cypress SLIT is desirable.

Identifiants

pubmed: 37967960
doi: 10.15036/arerugi.72.1138
doi:

Substances chimiques

Allergens 0

Types de publication

Multicenter Study English Abstract Journal Article

Langues

jpn

Sous-ensembles de citation

IM

Pagination

1138-1146

Auteurs

Aiko Oka (A)

Department of Otorhinolaryngology, Head and Neck Surgery, International University of Health and Welfare Narita Hospital.

Atsushi Yuta (A)

Yuta Clinic.

Yukiko Okawa (Y)

Yuta Clinic.

Satoru Masuno (S)

Mikinohara ENT Clinic.

Takatsugu Tsunoda (T)

Hidamari Clinic.

Eriko Takahara (E)

Chofu Ekimae ENT Clinic.

Akihiko Terada (A)

Terada Allergy Kodomo Clinic.

Kenichi Kanai (K)

Kosugi ENT Clinic.

Hitoshi Nagakura (H)

Nagakura ENT Allergy Clinic.

Hideya Mimura (H)

Mimura Clinic.

Harumi Arao (H)

Arao Internal Medicine and Otolaryngology Clinic.

Akiyo Ueyama (A)

Funai Clinic.

Reiko Tokuda (R)

Tokuda Family Clinic.

Hitoshi Bamba (H)

BAMBA ENT Clinic.

Hidehisa Nakazato (H)

Oyamanakamaru Clinic.

Mahoko Nakazato (M)

Oyamanakamaru Clinic.

Ryo Amesara (R)

Amesara ENT Clinic.

Shigeru Nakai (S)

Nakai ENT Clinic.

Susumu Araki (S)

Otaka no Mori ENT Morning Clinic.

Mayuko Sakaida (M)

Mie E.N.T. Clinic.

Masaharu Tokuriki (M)

Tokuriki ENT Clinic.

Takemitsu Hama (T)

Hama ENT Clinic.

Mayumi Chiba (M)

Chiba Dermatology and Otolaryngology Clinic.

Hiroki Ikeda (H)

Ikeda ENT Clinic.

Akihisa Togawa (A)

Sansan Clinic.

Hideaki Tsuzuki (H)

Miyako Ear, Nose and Throat Clinic.

Yukiyoshi Hyo (Y)

Hyo ENT Clinic.

Sumiko Niitsu (S)

Niitsu Clinic.

Chikahisa Ohkawa (C)

Okawa ENT Clinic.

Setsuo Nakamoto (S)

Nakamoto Ear Nose Throat Clinic.

Tetsu Takeo (T)

Takeo ENT Clinic.

Hiroshi Kumanomidou (H)

Kumanomidou ENT Clinic.

Kengo Kanai (K)

Department of Otorhinolaryngology, Head and Neck Surgery, International University of Health and Welfare Narita Hospital.

Hiroshi Kitamura (H)

Department of Otorhinolaryngology, Head and Neck Surgery, International University of Health and Welfare Narita Hospital.

Ruka Sugiura (R)

International University of Health and Welfare, School of Medicine.

Mitsuhiro Okano (M)

Department of Otorhinolaryngology, Head and Neck Surgery, International University of Health and Welfare Narita Hospital.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH